Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

HIV-infected patients with TB need simplified, effective and well-tolerated antiretroviral regimens. The French ANRS 129 BKVIR open trial evaluated the once-daily tenofovir DF/emtricitabine and efavirenz combination, started within 12 weeks after TB treatment initiation, in antiretroviral-naive HIV-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of antimicrobial chemotherapy 2016-03, Vol.71 (3), p.783-793
Hauptverfasser:	Lortholary, Olivier, Roussillon, Caroline, Boucherie, Céline, Padoin, Christophe, Chaix, Marie-Laure, Breton, Guillaume, Rami, Agathe, Veziris, Nicolas, Patey, Olivier, Caumes, Eric, May, Thierry, Molina, Jean-Michel, Robert, Jérome, Tod, Michel, Fagard, Catherine, Chêne, Geneviève
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-HIV Agents - administration & dosage Antiretroviral drugs Antitubercular Agents - administration & dosage Benzoxazines - administration & dosage Drug therapy Drug Therapy, Combination - methods Emtricitabine - administration & dosage Female France HIV HIV Infections - complications HIV Infections - drug therapy Human immunodeficiency virus Human immunodeficiency virus 1 Humans Immunology Life Sciences Male Middle Aged Mycobacterium Tenofovir - administration & dosage Treatment Outcome Tuberculosis Tuberculosis - drug therapy Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	HIV-infected patients with TB need simplified, effective and well-tolerated antiretroviral regimens. The French ANRS 129 BKVIR open trial evaluated the once-daily tenofovir DF/emtricitabine and efavirenz combination, started within 12 weeks after TB treatment initiation, in antiretroviral-naive HIV-1-infected patients. Success was defined as an HIV-1 RNA
ISSN:	0305-7453 1460-2091
DOI:	10.1093/jac/dkv384